| PDF - Published Version (1MB) |
- URN to cite this document:
- urn:nbn:de:bvb:355-epub-407526
- DOI to cite this document:
- 10.5283/epub.40752
Abstract
Background: This study was designed to evaluate the role of heat shock protein 90 (HSP90) in tumor progression of murine islet cell tumors. Blockade of HSP90 has recently been proposed as a therapeutic target, but effects in models of islet cell tumors with AUY922, a newly developed HSP90 inhibitor, have not been examined. Material and Methods: The carcinoid cell line BON-1 and the HSP90 ...

Owner only: item control page